{"version":"1.0","type":"rich","provider_name":"Buzzsprout","provider_url":"https://www.buzzsprout.com","author_url":"https://www.buzzsprout.com/803306","width":500,"thumbnail_width":600,"thumbnail_height":600,"title":"From the helm: Amplia Therapeutics (ASX:ATX), CEO & MD, Christopher Burns & Bell Potter Analyst, Thomas Wakim.","author_name":"Between the Bells","html":"<iframe src=\"https://www.buzzsprout.com/803306/episodes/18878498-from-the-helm-amplia-therapeutics-asx-atx-ceo-md-christopher-burns-bell-potter-analyst-thomas-wakim?client_source=oembed&amp;iframe=true\" width=\"100%\" height=\"200\" frameborder=\"0\" scrolling=\"no\" loading=\"lazy\" title=\"Between the Bells, From the helm: Amplia Therapeutics (ASX:ATX), CEO &amp; MD, Christopher Burns &amp; Bell Potter Analyst, Thomas Wakim.\"></iframe>","height":200,"thumbnail_url":"https://www.buzzsprout.com/rails/active_storage/representations/redirect/eyJfcmFpbHMiOnsiZGF0YSI6ODM5NTQ1NiwicHVyIjoiYmxvYl9pZCJ9fQ==--7e84e675d44a451abccb7cf024e5a9e24a2d0080/eyJfcmFpbHMiOnsiZGF0YSI6eyJmb3JtYXQiOiJqcGciLCJyZXNpemVfdG9fZmlsbCI6WzYwMCw2MDAseyJjcm9wIjoiY2VudHJlIn1dLCJzYXZlciI6eyJxdWFsaXR5Ijo2MH0sImNvbG91cnNwYWNlIjoic3JnYiJ9LCJwdXIiOiJ2YXJpYXRpb24ifX0=--0b154cb6b88107719b1a277923d35676ba5519cc/Between%20the%20Bells%20cover%20art%203000x3000%20FINAL.jpg"}